{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T08:12:41Z","timestamp":1769242361755,"version":"3.49.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006506","name":"Minist\u00e9rio da Sa\u00fade","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006506","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.ahj.2018.10.001","type":"journal-article","created":{"date-parts":[[2018,10,17]],"date-time":"2018-10-17T02:10:33Z","timestamp":1539742233000},"page":"40-48","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Rationale and design for a cluster randomized quality-improvement trial to increase the uptake of evidence-based therapies for patients at high cardiovascular risk: The BRIDGE-Cardiovascular Prevention trial"],"prefix":"10.1016","volume":"207","author":[{"given":"Maria Julia","family":"Machline-Carrion","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael Marques","family":"Soares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas Petri","family":"Damiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viviane Bezerra","family":"Campos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruna","family":"Sampaio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco H.","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Cristina","family":"Izar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celso","family":"Amodeo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Octavio Marques","family":"Pontes-Neto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro Gabriel","family":"de Melo Barros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renato D.","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nilton","family":"Brand\u00e3o da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9lio Penna","family":"Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leopoldo","family":"Piegas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Airton T.","family":"Stein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Otavio","family":"Berwanger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10100","key":"10.1016\/j.ahj.2018.10.001_bb0005","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0140-6736(17)32152-9","article-title":"Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"390","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ahj.2018.10.001_bb0010","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12963-017-0156-y","article-title":"Cause-specific mortality for 249 causes in Brazil and states during 1990-2015: a systematic analysis for the global burden of disease study 2015","volume":"15","author":"Franca","year":"2017","journal-title":"Popul Health Metr"},{"issue":"9493","key":"10.1016\/j.ahj.2018.10.001_bb0015","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins","volume":"366","author":"Baigent","year":"2005","journal-title":"Lancet"},{"issue":"9753","key":"10.1016\/j.ahj.2018.10.001_bb0020","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Cholesterol Treatment Trialists","year":"2010","journal-title":"Lancet"},{"issue":"7329","key":"10.1016\/j.ahj.2018.10.001_bb0025","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","author":"Antithrombotic Trialists C","year":"2002","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.ahj.2018.10.001_bb0030","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients","volume":"342","author":"Heart Outcomes Prevention Evaluation Study I","year":"2000","journal-title":"N Engl J Med"},{"issue":"9287","key":"10.1016\/j.ahj.2018.10.001_bb0035","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(01)06178-5","article-title":"Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack","volume":"358","author":"Group PC","year":"2001","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ahj.2018.10.001_bb0040","doi-asserted-by":"crossref","first-page":"212","DOI":"10.5935\/abc.20130062","article-title":"Evidence-based therapy prescription in high-cardiovascular risk patients: the REACT study","volume":"100","author":"Berwanger","year":"2013","journal-title":"Arq Bras Cardiol"},{"issue":"4","key":"10.1016\/j.ahj.2018.10.001_bb0045","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.gheart.2016.06.001","article-title":"Secondary CV Prevention in South America in a Community Setting: The PURE Study","volume":"12","author":"Avezum","year":"2017","journal-title":"Glob Heart"},{"issue":"Suppl. 2","key":"10.1016\/j.ahj.2018.10.001_bb0050","first-page":"S14","article-title":"Toward evidence-based quality improvement. Evidence (and its limitations) of the effectiveness of guideline dissemination and implementation strategies 1966\u20131998","volume":"21","author":"Grimshaw","year":"2006","journal-title":"J Gen Intern Med"},{"issue":"8 Suppl. 2","key":"10.1016\/j.ahj.2018.10.001_bb0055","first-page":"II2","article-title":"Changing provider behavior: an overview of systematic reviews of interventions","volume":"39","author":"Grimshaw","year":"2001","journal-title":"Med Care"},{"issue":"19","key":"10.1016\/j.ahj.2018.10.001_bb0060","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1001\/jama.2012.413","article-title":"Effect of a multifaceted intervention on use of evidence-based therapies in patients with acute coronary syndromes in Brazil: the BRIDGE-ACS randomized trial","volume":"307","author":"Berwanger","year":"2012","journal-title":"JAMA"},{"issue":"10104","key":"10.1016\/j.ahj.2018.10.001_bb0065","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/S0140-6736(17)32165-7","article-title":"A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trial","volume":"390","author":"Vinereanu","year":"2017","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.ahj.2018.10.001_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001346","article-title":"The Ottawa Statement on the Ethical Design and Conduct of Cluster Randomized Trials","volume":"9","author":"Weijer","year":"2012","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.ahj.2018.10.001_bb0075","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/CIRCOUTCOMES.114.001235","article-title":"Effect of a computer-guided, quality improvement program for cardiovascular disease risk management in primary health care: the treatment of cardiovascular risk using electronic decision support cluster-randomized trial","volume":"8","author":"Peiris","year":"2015","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.ahj.2018.10.001_bb0080","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s13012-015-0341-y","article-title":"A real-world stepped wedge cluster randomized trial of practice facilitation to improve cardiovascular care","volume":"10","author":"Liddy","year":"2015","journal-title":"Implement Sci"},{"issue":"1","key":"10.1016\/j.ahj.2018.10.001_bb0085","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13012-016-0450-2","article-title":"Testing the use of practice facilitation in a cluster randomized stepped-wedge design trial to improve adherence to cardiovascular disease prevention guidelines: HealthyHearts NYC","volume":"11","author":"Shelley","year":"2016","journal-title":"Implement Sci"},{"issue":"9798","key":"10.1016\/j.ahj.2018.10.001_bb0090","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(11)61215-4","article-title":"Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey","volume":"378","author":"Yusuf","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2018.10.001_bb0095","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1186\/1745-6215-14-354","article-title":"Cardiovascular disease risk reduction in rural China: a clustered randomized controlled trial in Zhejiang","volume":"14","author":"Wei","year":"2013","journal-title":"Trials"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870318302941?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870318302941?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:01:52Z","timestamp":1757570512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870318302941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":19,"alternative-id":["S0002870318302941"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2018.10.001","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rationale and design for a cluster randomized quality-improvement trial to increase the uptake of evidence-based therapies for patients at high cardiovascular risk: The BRIDGE-Cardiovascular Prevention trial","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2018.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}